Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 25, 2026

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

Deep Unsupervised Domain Adaptation for Translating Cancer Dependency Maps From Cell Lines to Breast Cancer Tumor

Yu Shi1, Wei Xu1,2, Pingzhao Hu1,3,4,5,6

  • 1Biostatistics Division, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Genetic Epidemiology
|June 24, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generative AI for the Design of Molecules: Advances and Challenges.

Journal of chemical information and modeling·2025
Same author

MolGraph-xLSTM as a graph-based dual-level xLSTM framework for enhanced molecular representation and interpretability.

Communications chemistry·2025
Same author

Enhanced Interpretable Neural Network Approach for Unified Batch Effect Mitigation and Disease Classification Using Cross-Cohort Microbiome Profiles.

Journal of computational biology : a journal of computational molecular cell biology·2025
Same author

GraphBAN: An inductive graph-based approach for enhanced prediction of compound-protein interactions.

Nature communications·2025
Same author

Conditional probabilistic diffusion model driven synthetic radiogenomic applications in breast cancer.

PLoS computational biology·2024
Same author

Investigating alignment-free machine learning methods for HIV-1 subtype classification.

Bioinformatics advances·2024
Same journal

Individualized Bayesian Inference Identifies Novel Genetic Variants for Parkinson's Disease.

Genetic epidemiology·2026
Same journal

DRIVE v3: Command Line Application for Identity-by-Descent Haplotype Clustering in Large Biobank Scale Data.

Genetic epidemiology·2026
Same journal

Polygenic Risk Scores for Incident Dementia in the Multi-Ethnic Study of Atherosclerosis.

Genetic epidemiology·2026
Same journal

Outcome and Exposure Polygenic Risk Scores Can Help Reduce Information Bias and Selection Bias in Regression Estimates From Biobank Data.

Genetic epidemiology·2026
Same journal

Comment on: A Novel Mendelian Randomization Method With Binary Risk Factor and Outcome.

Genetic epidemiology·2026
Same journal

Shared and Distinct Genetic Factors Underlying Bile Acid Regulation and Intrahepatic Cholestasis of Pregnancy.

Genetic epidemiology·2026
See all related articles
This summary is machine-generated.

We developed a deep unsupervised domain adaptation algorithm to predict cancer dependencies in patient tumors. This approach improves the translation of preclinical findings into personalized cancer treatments, identifying potential drug targets for breast cancer.

Area of Science:

  • Computational biology
  • Genomics
  • Precision medicine

Background:

  • Cancer dependency maps (DepMap) identify genetic vulnerabilities using loss-of-function screens.
  • Discrepancies between cancer cell line models and patient tumors hinder clinical translation.
  • Artificial intelligence, specifically domain adaptation, can bridge this gap by aligning molecular data.

Purpose of the Study:

  • To develop and validate a deep unsupervised domain adaptation (UDA) algorithm for aligning cancer cell line and patient tumor data.
  • To predict cancer dependency maps for breast cancer (BC) patients using The Cancer Genome Atlas (TCGA) data.
  • To assess the utility of predicted dependency maps for subtype classification and synthetic lethality (SL) discovery.

Main Methods:

  • Trained a deep UDA algorithm on labeled cancer cell line data (source domain) and unlabeled patient data (target domain).
Keywords:
The Cancer Genome Atlas (TCGA)breast cancercancer dependency mapdomain adaptationsynthetic lethality

More Related Videos

Depletion of Mouse Cells from Human Tumor Xenografts Significantly Improves Downstream Analysis of Target Cells
07:10

Depletion of Mouse Cells from Human Tumor Xenografts Significantly Improves Downstream Analysis of Target Cells

Published on: July 29, 2016

Related Experiment Videos

Last Updated: Jun 25, 2026

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

Depletion of Mouse Cells from Human Tumor Xenografts Significantly Improves Downstream Analysis of Target Cells
07:10

Depletion of Mouse Cells from Human Tumor Xenografts Significantly Improves Downstream Analysis of Target Cells

Published on: July 29, 2016

  • Applied the trained model to predict BC dependency maps from TCGA data.
  • Validated the model by classifying ER+/HER2+ BC subtypes and identifying SL gene pairs.

    • Main Results:

    • The UDA model accurately predicted cancer dependency maps for patient-derived tumors.
    • The predicted maps achieved high accuracy (AUC-ROC 0.99) in classifying ER+/HER2+ BC subtypes.
    • Identified two potential synthetic lethality gene pairs (PBRM1-NF2 and PBRM1-CTNND2) for precision therapy development.

    Conclusions:

    • Deep unsupervised domain adaptation is a powerful approach for transferring biological knowledge between cancer models.
    • This method enhances the translation of preclinical findings into patient-specific treatment strategies.
    • The identified SL pairs offer potential therapeutic targets for ER+/HER2+ breast cancer.